Loading
JPXHealthcareMedical - Pharmaceuticals
Latest quote
¥2,199
−¥19.00 · -0.86%
Headquartered in Tokyo, Japan, Qol Holdings Co., Ltd., established in 1992, operates a diverse portfolio of businesses, primarily focusing on dispensing pharmacies and business process outsourcing (BPO) within the healthcare sector. The company establishes its dispensing pharmacies through tailored, trust-based relationships with individual medical institutions. Beyond its pharmacy operations, Qol Holdings provides extensive BPO services, including conducting sales and marketing research for pharmaceutical companies. It also specializes in dispatching temporary staff across various medical professions, such as pharmacists, nurses, registered sellers, and dietitians. Additionally, the company offers comprehensive support for clinical trials involving both pharmaceuticals and food products. This support encompasses a broad spectrum of services, from assisting with trial execution planning and monitoring to providing secretariat support, statistical analysis, and facilitating the presentation of conference papers, often through the dispatch of skilled managers and technicians. The company further extends its offerings to include publishing-related services. Originally named Qol Co., Ltd., the company adopted its current name, Qol Holdings Co., Ltd., in October 2018.
Latest quote
¥2,199
−¥19.00 · -0.86%
Regular session · JST · Market data may be delayed.
Headquartered in Tokyo, Japan, Qol Holdings Co., Ltd., established in 1992, operates a diverse portfolio of businesses, primarily focusing on dispensing pharmacies and business process outsourcing (BPO) within the healthcare sector. The company establishes its dispensing pharmacies through tailored, trust-based relationships with individual medical institutions. Beyond its pharmacy operations, Qol Holdings provides extensive BPO services, including conducting sales and marketing research for pharmaceutical companies. It also specializes in dispatching temporary staff across various medical professions, such as pharmacists, nurses, registered sellers, and dietitians. Additionally, the company offers comprehensive support for clinical trials involving both pharmaceuticals and food products. This support encompasses a broad spectrum of services, from assisting with trial execution planning and monitoring to providing secretariat support, statistical analysis, and facilitating the presentation of conference papers, often through the dispatch of skilled managers and technicians. The company further extends its offerings to include publishing-related services. Originally named Qol Co., Ltd., the company adopted its current name, Qol Holdings Co., Ltd., in October 2018.
Day range
Current ¥2,199
52-week range
Current ¥2,199
Regular session · JST · Market data may be delayed.
Headquartered in Tokyo, Japan, Qol Holdings Co., Ltd., established in 1992, operates a diverse portfolio of businesses, primarily focusing on dispensing pharmacies and business process outsourcing (BPO) within the healthcare sector. The company establishes its dispensing pharmacies through tailored, trust-based relationships with individual medical institutions. Beyond its pharmacy operations, Qol Holdings provides extensive BPO services, including conducting sales and marketing research for pharmaceutical companies. It also specializes in dispatching temporary staff across various medical professions, such as pharmacists, nurses, registered sellers, and dietitians. Additionally, the company offers comprehensive support for clinical trials involving both pharmaceuticals and food products. This support encompasses a broad spectrum of services, from assisting with trial execution planning and monitoring to providing secretariat support, statistical analysis, and facilitating the presentation of conference papers, often through the dispatch of skilled managers and technicians. The company further extends its offerings to include publishing-related services. Originally named Qol Co., Ltd., the company adopted its current name, Qol Holdings Co., Ltd., in October 2018.
Day range
Current ¥2,199
52-week range
Current ¥2,199
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 290.77B JPY | 263.97B JPY | 180.05B JPY | 170.04B JPY | 166.2B JPY |
| Cost of goods sold | 254.15B JPY | 229.25B JPY | 156.8B JPY | 146.53B JPY | 143.04B JPY |
| Gross profit | 36.62B JPY | 34.73B JPY | 23.25B JPY | 23.51B JPY | 23.16B JPY |
| Selling, general, and administrative | 21.87B JPY | 21.26B JPY | 11.53B JPY | 10.81B JPY | 10.14B JPY |
| Operating expenses | 21.87B JPY | 21.26B JPY | 14.93B JPY | 14.01B JPY | 13.31B JPY |
| Interest expense | 366M JPY | 223M JPY | 109M JPY | 89M JPY | 101M JPY |
| Depreciation and amortization | 9.81B JPY | 8.36B JPY | 5.24B JPY | 4.88B JPY | 4.73B JPY |
| Operating income | 14.75B JPY | 13.47B JPY | 8.32B JPY | 9.5B JPY | 9.86B JPY |
| Net income | 7.41B JPY | 5.16B JPY | 4.88B JPY | 5.66B JPY | 5.49B JPY |
Company facts updated Sep 12, 2026.
Recent quarterly results
Recent quarterly results
Cash distributions grouped by calendar year; partial years are marked.
¥40.00
2025 complete year+42.9% since 2021
2026 partial: ¥27.00
¥28.00
2,021
¥29.00
2,022
¥32.00
2,023
¥32.00
2,024
¥40.00
2,025
¥27.00
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Sep 29, 2026 | ¥27.00Semi-Annual | Sep 30, 2026 | Sep 29, 2026 |
DividendUpcoming | Mar 30, 2027 | ¥27.00Semi-Annual | Mar 31, 2027 | Mar 30, 2027 |
Dividend | Mar 30, 2026 | ¥27.00Semi-Annual | Mar 31, 2026 | Jun 12, 2026 |
Dividend | Sep 29, 2025 | ¥23.00Semi-Annual | Sep 30, 2025 | Dec 1, 2025 |
Dividend | Mar 28, 2025 | ¥17.00Semi-Annual | Mar 31, 2025 | Jun 12, 2025 |
Dividend | Sep 27, 2024 | ¥17.00Semi-Annual | Sep 30, 2024 | Dec 2, 2024 |
Ex-dividend Sep 29, 2026
¥27.00
Semi-Annual
Record Sep 30, 2026 · Payment Sep 29, 2026
Ex-dividend Mar 30, 2027
¥27.00
Semi-Annual
Record Mar 31, 2027 · Payment Mar 30, 2027
Ex-dividend Mar 30, 2026
¥27.00
Semi-Annual
Record Mar 31, 2026 · Payment Jun 12, 2026
Ex-dividend Sep 29, 2025
¥23.00
Semi-Annual
Record Sep 30, 2025 · Payment Dec 1, 2025
Ex-dividend Mar 28, 2025
¥17.00
Semi-Annual
Record Mar 31, 2025 · Payment Jun 12, 2025
Ex-dividend Sep 27, 2024
¥17.00
Semi-Annual
Record Sep 30, 2024 · Payment Dec 2, 2024
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core TOPIX ETF1475.T148.38M0.01%2.91T JPY0.05%¥413.5-0.48%
Vanguard Total International Stock ETFVXUS3.88M0.00%646.2B USD0.05%$87.14+1.00%
Vanguard FTSE Developed Markets ETFVEA1.95M0.00%315B USD0.03%$72.69+1.07%
Dimensional - International Small Cap ETFDFIS840.12K0.01%5.85B USD0.39%$37.12+0.68%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS771.39K0.01%13.6B USD0.06%$158.56+0.72%
Dimensional - International Core Equity 2 ETFDFIC636.95K0.00%15.36B USD0.22%$38.925+0.82%
Schwab International Small-Cap Equity ETFSCHC615.41K0.01%5.7B USD0.06%$50.72+0.63%
Dimensional - International Core Equity Market ETFDFAI330.15K0.00%18.14B USD0.18%$42.77+0.92%iShares Core TOPIX ETF1475.TVanguard Total International Stock ETFVXUSVanguard FTSE Developed Markets ETFVEADimensional - International Small Cap ETFDFISVanguard FTSE All-World ex-US Small-Cap ETFVSSDimensional - International Core Equity 2 ETFDFICSchwab International Small-Cap Equity ETFSCHCDimensional - International Core Equity Market ETFDFAIAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
